Glatiramer Acetate int 42267-27-6 , Product Name: N-(4-(2,5-Dioxo-4-oxazolidinyl)butyl)-2,2,2-trifluoroacetamide
AI Product Description
*The following content is generated by AI and is for reference only.
<h3>Overview</h3>
<p>Glatiramer Acetate (CAS <strong>42267-27-6</strong>) is a synthetic copolymer of amino acids, primarily L-glutamic acid, L-alanine, L-tyrosine, and L-lysine. It functions as an immunomodulator manufactured via controlled polymerization.</p>
<h3>Application</h3>
<ul>
<li><strong>Multiple Sclerosis Treatment:</strong> First-line therapy for relapsing-remitting MS to reduce attack frequency.</li>
<li><strong>Neurology Research:</strong> Used in clinical trials exploring autoimmune modulation mechanisms.</li>
<li><strong>Diagnostics:</strong> Employed in assays evaluating T-cell reactivity profiles.</li>
</ul>
<h3>Precautions</h3>
<p>Requires strict refrigeration at 2–8°C prior to use. Injection site reactions are common; patients must be monitored for immediate hypersensitivity. Contraindicated in individuals with known severe allergies to component amino acids.</p>